Cargando…

Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms

OBJECTIVE: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the etiologic agent of the current, world-wide coronavirus disease 2019 (COVID-19) pandemic. Angiotensin-converting enzyme 2 (ACE2) is the SARS-CoV-2 host entry receptor for cellular inoculation and target organ injury. We re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Baohui, Li, Gang, Guo, Jia, Ikezoe, Toru, Kasirajan, Karthikeshwar, Zhao, Sihai, Dalman, Ronald L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the Society for Vascular Surgery. Published by Elsevier Inc. 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944865/ https://www.ncbi.nlm.nih.gov/pubmed/33600934 http://dx.doi.org/10.1016/j.jvs.2021.01.051

Ejemplares similares

Acute upper extremity ischemia and symptomatic popliteal artery aneurysm secondary to coronavirus disease 2019
por: Kasirajan, Karthikeshwar
Publicado: (2021)

Type I Interferon Receptor Subunit 1 Deletion Attenuates Experimental Abdominal Aortic Aneurysm Formation
por: Shoji, Takahiro, et al.
Publicado: (2022)

No Effect of Hypercholesterolemia on Elastase-Induced Experimental Abdominal Aortic Aneurysm Progression
por: Ikezoe, Toru, et al.
Publicado: (2021)

Pharmacological Inhibition of Gasdermin D Suppresses Angiotensin II-Induced Experimental Abdominal Aortic Aneurysms
por: Guo, Jia, et al.
Publicado: (2023)

Efficacy and Mechanism of Angiotensin II Receptor Blocker Treatment in Experimental Abdominal Aortic Aneurysms
por: Iida, Yasunori, et al.
Publicado: (2012)

Mechanisms and efficacy of metformin-mediated suppression of established experimental abdominal aortic aneurysms
por: Xu, Baohui, et al.
Publicado: (2023)

Recombinant Interleukin‐19 Suppresses the Formation and Progression of Experimental Abdominal Aortic Aneurysms
por: Tanaka, Hiroki, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Treatment With Small Molecule Inhibitors of Advanced Glycation End‐Products Formation and Advanced Glycation End‐Products‐Mediated Collagen Cross‐Linking Promotes Experimental Aortic Aneurysm Progression in Diabetic Mice
por: Li, Yankui, et al.
Publicado: (2023)

The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019
por: Zhu, Zhe, et al.
Publicado: (2020)

Retrograde superficial femoral artery recanalization through a deep femoral collateral: A transradial approach
por: Kasirajan, Karthikeshwar
Publicado: (2023)

Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System
por: Edmonston, Daniel L., et al.
Publicado: (2020)

Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019
por: Suh, Sang Heon, et al.
Publicado: (2021)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Rossato, Marco, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
por: Gupta, Nitesh, et al.
Publicado: (2020)

Angiotensin‐converting enzyme 2 as a versatile player in the management of coronavirus disease 2019
por: Amano, Tetsuya
Publicado: (2020)

The role and significance of angiotensin‐converting enzyme 2 peptides in the treatment of coronavirus disease 2019
por: Liu, Yang, et al.
Publicado: (2021)

Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers increases the risk of postoperative acute kidney injury after elective endovascular abdominal aortic aneurysm repair
por: Xiang, Yuwei, et al.
Publicado: (2022)

Serum angiotensin-converting enzyme 2 is an independent risk factor for in-hospital mortality following open surgical repair of ruptured abdominal aortic aneurysm
por: Nie, Wanpin, et al.
Publicado: (2016)

An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK)
por: Bicknell, Colin D., et al.
Publicado: (2016)

Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019
por: Zheng, Haoyi, et al.
Publicado: (2020)

Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
por: Liu, Meng-Yuan, et al.
Publicado: (2020)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Komiyama, Maki, et al.
Publicado: (2020)

Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019
por: Oddy, Christopher, et al.
Publicado: (2021)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Pemafibrate Prevents Rupture of Angiotensin II-Induced Abdominal Aortic Aneurysms
por: Amioka, Naofumi, et al.
Publicado: (2022)

ACE Inhibitors Potently Reduce Vascular Inflammation, Results of an Open Proof-Of-Concept Study in the Abdominal Aortic Aneurysm
por: Kortekaas, Kim E., et al.
Publicado: (2014)

Potential use of the S-protein–Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019
por: Feng, Long, et al.
Publicado: (2022)

Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary Aneurysms
por: Lamblin, Nicolas, et al.
Publicado: (2003)

Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2)
por: Zemlin, Annalise E, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
por: Sommerstein, Rami, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

The Cell Biology of the SARS Coronavirus Receptor, Angiotensin-Converting Enzyme 2
por: Lambert, Daniel W.
Publicado: (2009)

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
por: Li, Wenhui, et al.
Publicado: (2003)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children?
por: Eun, Lucy Youngmin
Publicado: (2021)

Reassessing the Operative Threshold for Abdominal Aortic Aneurysm Repair in the Context of Coronavirus Disease 2019
por: McGuinness, Brandon, et al.
Publicado: (2020)

Kunming mouse strain is less susceptible to elastase‐induced abdominal aortic aneurysms
por: Liu, Haole, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ec31qsith2ifd58bsd8co9toeq